Replies to post #1322 on Vaso Corporation (VASO)

[OBrien]

Just so much uncertainty now taken out of the stock that has been holding it down....

Subsequent Event

In April 2020, the Company extended the maturity dates of its lines of credit and MedTech Notes to April 30, 2021 and made principal payments aggregating $1.2 million on its lines of credit and $1.2 million on its MedTech Notes. The interest rate on the MedTech Notes was also reduced from 10% to 6% per annum. In addition, in March 2020 and April 2020 the maturity dates of $930 thousand in other related party notes was extended six months and the interest rate was reduced from 10% to 8% per annum.